Previous 10 | Next 10 |
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Organogenesis To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - October 14, 2021) - Faruqi & Faruqi, LLP, a leading national securitie...
BOSTON, Oct. 12, 2021 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Organogenesis Holdings, Inc. (NASDAQ: ORGO) for potential securities law violations. Investors who have lost money in their Organogenesis Holdings, Inc. investment should contact the firm to learn more about ...
Gainers: Nutriband (NTRBW) +97%. Nutriband (OTCQB:NTRB) +41%. R. R. Donnelley & Sons (NYSE:RRD) +38%. Tiptree (NASDAQ:TIPT) +27%. Inhibrx (NASDAQ:INBX) +24%. Weatherford (NASDAQ:WFRD) +20%. NRx Pharmaceuticals (NASDAQ:NRXP) +19%. Xiaobai Maimai (NASDAQ:HX) +19%. Ocugen (NASDAQ:OCGN) +16%....
Gainers: Nutriband (NTRBW) +84%, Nutriband (OTCQB:NTRB) +38%, Inhibrx (NASDAQ:INBX) +29%, Titan Pharmaceuticals (NASDAQ:TTNP) +14%, Quanterix (NASDAQ:QTRX) +17%. Losers: Organogenesis (NASDAQ:ORGO) -17%, Trevi Therapeutics (NASDAQ:TRVI) -11%,&...
CANTON, Mass., Oct. 07, 2021 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, to...
Healthcare had a slow start but now is one of the leading sectors in terms of 2021 performance. Healthcare is well-positioned to benefit from growing spending and pent-up demand. The sector is also a defensive investment if economic growth concerns mount. Regulatory risk remai...
Net Health Partners with Organogenesis for More Efficient Insurance Benefits Verification Agreement streamlines insurance verification process PR Newswire PITTSBURGH , Aug. 23, 2021 /PRNewswire/ -- Net Health , a leading provider of cloud-based software f...
Image source: The Motley Fool. Organogenesis Holdings Inc (NASDAQ: ORGO) Q2 2021 Earnings Call Aug 09, 2021 , 5:00 p.m. ET Operator Continue reading For further details see: Organogenesis Holdings Inc (ORGO) Q2 2021 Earnings Call Transcri...
Organogenesis Holdings Inc. (ORGO) Q2 2021 Earnings Conference Call August 9, 2021 5:00 PM ET Company Participants Gary Gillheeney – President and Chief Executive Officer Dave Francisco – Chief Financial Officer Conference Call Participants Ryan Zimmerman – BTIG Matt Miks...
CANTON, Mass., Aug. 09, 2021 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, to...
News, Short Squeeze, Breakout and More Instantly...
Organogenesis Holdings Inc. Company Name:
ORGO Stock Symbol:
NASDAQ Market:
Organogenesis Holdings Inc. Website:
CANTON, Mass., July 15, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, to...
2024-06-28 10:00:07 ET Brooks O'Neil from Lake Street issued a price target of $5.00 for ORGO on 2024-06-28 08:01:00. The adjusted price target was set to $5.00. At the time of the announcement, ORGO was trading at $2.64. ORGO currently trades -43.21% versus its 52 week ...
CANTON, Mass., June 06, 2024 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets, today an...